MDPI and ACS Style
Tsai, K.-Y.; Wei, P.-L.; Lee, C.-C.; Makondi, P.T.; Chen, H.-A.; Chang, Y.-Y.; Liu, D.-Z.; Huang, C.-Y.; Chang, Y.-J.
2,3,5,4′-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy. Biomedicines 2023, 11, 1798.
https://doi.org/10.3390/biomedicines11071798
AMA Style
Tsai K-Y, Wei P-L, Lee C-C, Makondi PT, Chen H-A, Chang Y-Y, Liu D-Z, Huang C-Y, Chang Y-J.
2,3,5,4′-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy. Biomedicines. 2023; 11(7):1798.
https://doi.org/10.3390/biomedicines11071798
Chicago/Turabian Style
Tsai, Kuei-Yen, Po-Li Wei, Cheng-Chin Lee, Precious Takondwa Makondi, Hsin-An Chen, Yao-Yuan Chang, Der-Zen Liu, Chien-Yu Huang, and Yu-Jia Chang.
2023. "2,3,5,4′-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy" Biomedicines 11, no. 7: 1798.
https://doi.org/10.3390/biomedicines11071798